Premier Alternatives

Sonire Therapeutics

Tokyo, Japan · Founded 2020 · Privately Held (backing)

Developer of high-intensity focused ultrasound therapy systems designed to revolutionize medical therapy for the treatment of cancer patients. Sonire Therapeutics is based in Tokyo, Japan and was founded in 2020. Its last reported valuation was $31.7 million in Nov 2022. It has raised $39.9 million across 1 recorded round; the latest was a $13.5 million early-stage round in Mar 2026.

Last reported valuation
$31.7M
Oct 2026
Priced at
—
Total raised
$39.9M
Last round
Early Stage VC
Mar 2026

Sonire Therapeutics key facts

as of Oct 2026
  • Developer of high-intensity focused ultrasound therapy systems designed to revolutionize medical therapy for the treatment of cancer patients.
  • Sonire Therapeutics is valued at approximately $31.7M as of Oct 2026 (last reported valuation).
  • It has raised $39.9M across 1 recorded rounds; the latest was Early Stage VC ($13.5M) in Mar 2026.
  • Notable investors include MedTech Innovator, Mitsubishi UFJ Capital, SBI Investment, J-Startup, Nissay Capital — 27 tracked in total.
  • Sonire Therapeutics has filed 1 Form D with the SEC, most recently Apr 2026 ($13.5M sold to 1 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$31.7M

Sonire Therapeutics's last reported valuation, Nov 2022. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Sonire Therapeutics with a free account
  • ·The complete investor list: 27 names
  • ·Watch Sonire Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Sonire Therapeutics funding rounds

1 rounds
Mar 2026Early Stage VC$13.5MSEC filing▮
Full funding history →

Sonire Therapeutics valuation

Sonire Therapeutics's last reported valuation was $31.7 million in Nov 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Sonire Therapeutics raised?

Sonire Therapeutics has raised $39.9 million in total; 1 of its rounds is on record. The largest on record was a $13.5 million early-stage round in Mar 2026.

Sonire Therapeutics has filed 1 Form D with the SEC, most recently in Apr 2026 ($13.5 million sold to 1 investor).

Sonire Therapeutics investors

27 investors are on record for Sonire Therapeutics, including MedTech Innovator, Mitsubishi UFJ Capital, SBI Investment and J-Startup. The early-stage round in Mar 2026 drew 1 investor.

Who runs Sonire Therapeutics

3 people are listed on the Sonire Therapeutics team: 3 board members. 1 of them have a verified direct contact on file.

About Sonire Therapeutics

Developer of high-intensity focused ultrasound therapy systems designed to revolutionize medical therapy for the treatment of cancer patients. The company offers precise tissue targeting and real-time imaging capabilities, enabling healthcare professionals specializing in oncology and non-invasive surgery to deliver effective treatments with enhanced accuracy and patient comfort.

Sector
Healthcare
HQ
Tokyo, Japan
Founded
2020
Employees
27
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.